[A case of intravascular malignant lymphomatosis presenting as cerebral infarction]

T Satow1, S Nabeshima, N Yamazoe

  • 1Department of Neurosurgery, Tenri Hospital, Japan.

Insights

Intravascular malignant lymphomatosis (IML) is a rare condition causing progressive dementia and cerebral infarction. Early diagnosis, often requiring brain biopsy, is crucial for potential treatment, though outcomes remain challenging.

Area of Science:

  • Neurology
  • Oncology
  • Pathology

Background:

  • Intravascular malignant lymphomatosis (IML) is a rare neoplastic disorder characterized by the proliferation of lymphoid cells within small blood vessels.
  • Neurological manifestations are common in IML, often presenting as the primary clinical feature.

Observation:

  • A previously healthy 62-year-old male presented with progressive dementia and multiple cerebral infarcts on MRI.
  • The patient exhibited high fever, elevated C-reactive protein (CRP), lactate dehydrogenase (LDH), and soluble IL-2 receptor (sIL-2R).
  • Initial muscle biopsy was inconclusive, but subsequent brain biopsy confirmed the diagnosis of IML.

Findings:

  • Progressive dementia and multifocal cerebral infarctions are key indicators of IML.
  • Elevated inflammatory markers (CRP) and lymphoma markers (LDH, sIL-2R) support the diagnosis.
  • Brain biopsy is essential for definitive diagnosis when other methods are inconclusive.

Implications:

  • This case highlights the importance of considering IML in patients with rapidly progressive dementia and unexplained multiple cerebral infarcts.
  • Prompt diagnosis and treatment, though challenging, are critical for managing this rare condition.
  • Further research into diagnostic strategies and therapeutic interventions for IML is warranted.